WOLVERINE TRADING, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 243 filers reported holding HAEMONETICS CORP in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
WOLVERINE TRADING, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$490,451
+131.2%
5,475
+119.0%
0.00%
Q2 2023$212,100
+59985.0%
2,500
-43.2%
0.00%
-100.0%
Q1 2023$353
-99.9%
4,400
-12.0%
0.00%
Q4 2021$268,000
-95.8%
5,000
-94.8%
0.00%
-100.0%
Q2 2021$6,386,000
+867.6%
95,700
+1159.2%
0.01%
+400.0%
Q3 2020$660,000
-45.5%
7,600
-44.8%
0.00%
-50.0%
Q2 2020$1,211,000
+57.9%
13,766
+105.5%
0.00%
+100.0%
Q3 2018$767,000
+242.4%
6,700
+118.9%
0.00%
+100.0%
Q2 2018$224,0000.0%3,0610.0%0.00%0.0%
Q1 2018$224,0003,0610.00%
Other shareholders
HAEMONETICS CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders